Regulatory Support for MedTech Companies



Market Opportunity
The EU, UK and US can be highly attractive markets for MedTech companies, but expanding into them successfully takes more than a good product. Each market has its own regulatory framework, evidence requirements and route to market, so regulatory strategy needs to be considered early and treated as part of the wider commercial plan.
The opportunity is considerable. Europe alone is a €170 billion MedTech market with more than 38,000 companies operating across the sector. In the UK, the MedTech industry includes 4,360 companies and employs 196,000 people. In the US, the FDA authorized 124 novel medical devices in 2025 alone. For companies looking to enter or grow in these markets, the issue is usually not whether regulation matters, but how to approach it in a way that is practical, proportionate and aligned with the business.
When handled properly, regulatory planning does more than support compliance. It helps reduce delays, manage risk more effectively and create a clearer path to market, making growth more efficient and more sustainable over time.
Our Company
At MG Regulatory, we help MedTech companies navigate the regulatory demands of the EU, UK and US markets with clarity and confidence. With over 10 years of experience in the medical device industry, we advise on EU MDR, UK MDR and FDA requirements, as well as the development of audit-ready technical documentation aligned with ISO 13485 and ISO 14971.
We have supported more than 100 medical device projects across Class I to Class III devices, including software, diagnostics and implantable technologies. Our experience spans the full product lifecycle, allowing us to provide practical regulatory support that is proportionate to the stage, complexity and objectives of each project.
Our consultants bring experience from across the sector, including the World Health Organization, MHRA, Notified Bodies, large manufacturers and early-stage companies. That breadth of perspective allows us to combine technical rigour with a hands-on, commercially aware approach, delivering end-to-end regulatory support that is both high quality and practical.
We understand the challenges that come with navigating complex regulatory frameworks, and we work closely with clients to provide clear, reliable guidance throughout the process.
Organisations We Work With
Our Presence
Services
Our Services
We provide specialist regulatory support to help MedTech companies navigate market entry, maintain compliance and progress with confidence across the EU, UK and US.
Testimonials
Process
Our Regulatory Process
Our approach provides a clear and structured path through regulatory requirements across the EU, UK and US, helping medical device companies move from early planning to market readiness and ongoing compliance with confidence.
Scoping & Regulatory Assessment
We begin by understanding your device, intended use, target markets and stage of development to identify the applicable regulatory pathway and key requirements.
Regulatory Strategy
We define a practical regulatory strategy aligned with your product, market objectives and commercial timelines, covering classification, route to market and core compliance priorities.
Documentation & Market Readiness
We support the preparation and review of technical documentation, risk management files and supporting regulatory materials to ensure readiness for submission, registration or conformity assessment.
Submission & Ongoing Compliance
We support clients through submission, registration and post-market obligations, helping maintain compliance as products move into and remain in the market.
Book Consultation
Whether you are preparing for market entry, addressing a specific regulatory challenge or strengthening ongoing compliance, we provide expert guidance tailored to your product and target markets.












MG Regulatory’s project plan mapped out every step of our regulatory submission in minute detail, which kept us on track for a smooth CE mark application. When unexpected questions came back from our notified body, the team responded quickly, often within 24 hours, without compromising on quality.